Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats

doi:10.3748/wjg.v11.i38.5938

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2931)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

230

HTML

2262

Figures (1-5)

231

Tables (1-5)

208

Sum=2931

Oct 14, 2005 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Oct 14, 2005; 11(38): 5938-5943
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.5938

Full Size Figure Download Figure

Figure 3 Changes of cell cycle phases after treatment. A: The control group (4 weeks after NS injection); B: the treatment group (4 weeks after medium-dose As₂O₃ injection, obvious hypodiploid peak).

Citation: Tan B, Huang JF, Wei Q, Zhang H, Ni RZ. Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats. World J Gastroenterol 2005; 11(38): 5938-5943
URL: https://www.wjgnet.com/1007-9327/full/v11/i38/5938.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i38.5938